Europe Prosthetic Heart Valve Market, by Type (Mechanical Heart Valve, Transcatheter Heart Valves And Tissue Heart Valve) By Country - Europe Forecast to 2021
The introduction of valve replacement surgery in the early 1960s has dramatically improved the outcome of patients with valvular heart disease. A prosthetic heart valve is an artificial valve placed in the heart of thea patient suffering from valvular heart disease. In cases of the malfunctioning of any of the four natural valves, a surgery can be performed treplace it with a prosthetic valve. Heart valve disease can occur in any single valve or a combination of the four valves; however, the diseases of the aortic and mitral valves are the most common. A prosthetic heart valve can be either mechanical valve or tissue (bio-prosthetic) valve.
The purpose of this report is tcover the description, definition and forecast of the Europe Prosthetic Heart Valve market. It involves deep dive analysis of market segmentation, which comprises of products and country. The Europe prosthetic heart valve market was estimated grow from USD 1.13 billion in 2015 USD 1.93 Billion in 2021, at a CAGR of 9.3%.
Rising in aging population, technological advancements, and increased prevalence of heart valve disease are some of the factors influencing the growth of the prosthetic heart valve market. By type, the Europe Prosthetic Heart Valve market is divided intMechanical heart valve, Transcatheter heart valves and Tissue heart valve. The Transcatheter heart valve segment contributed the largest share of 48.3% tthe prosthetic heart valve market in Germany.
In-depth market share analysis, by revenue, of the top companies is alsincluded in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports, and interviews with industry experts and key opinion leaders, such as CEOs, directors, and marketing executives.
The major players in this market include Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Sorin S.p.A (Italy), Medtronic (Republic of Ireland), Abbot Laboratories (U.S.), Claret Medical, Inc. (U.S.), AorTech (U.K.), Edwards Lifesciences Corporation (U.S.), Neovasc Inc. (Canada), JenaValve Technology (Germany), among others. These companies have adopted various strategies, such as mergers & acquisitions and partnerships, among others, tachieve growth in the Europe Prosthetic Heart Valve market.
Scope of the Report:
This report categorizes the Europe market for Europe Prosthetic Heart Valve on the basis of type and country.
Market Segmentation, by Type:
Based on type, the Europe Europe Prosthetic Heart Valve market is segmented intmechanical heart valves, tissue heart valves, and transcatheter heart valve.
Market Segmentation, by Country:
- The Netherlands
- Prosthetic heart valve companies
- Government and Research Organizations
- Private Medical Offices
- Emergency Care Units
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of product portfoliof each company mapped at the country and subsegment level
- End-user adoption rate analysis of products (segment and country-wise)
- Comprehensive coverage of product approvals, volume data, pipeline products, and product recalls
- Brand/product perception matrix
Europe Cardiac Monitoring Devices Market Research Report
There are 6 segments such as Cardiac Rhythm Management Devices, Electrocardiogram, Holter Monitors, Event Monitors, Implantable Loop Recorder and Cardiac Output Monitoring Devices.
Europe Cardiac Output Monitoring Devices Market Research Report
There are sub segments- invasive, non-invasive and minimally invasive.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement